Switching from subcutaneous to oral semaglutide in type 2 diabetes: A prospective study.

Authors :: Martínez-Montoro JI
Picón-César MJ
Generoso-Piñar M
Fernández-Valero A
López-Montalbán Á
Simón-Frapolli VJ
Hernández-Bayo J
Pinzón-Martín JL
Tinahones FJ
Source :: Journal of internal medicine [J Intern Med] 2024 Jan; Vol. 295 (1), pp. 113-115. Date of Electronic Publication: 2023 Oct 30.
Publication Year :: 2024

Subjects :: Humans
Prospective Studies
Hypoglycemic Agents therapeutic use
Glucagon-Like Peptides therapeutic use
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 drug therapy

Full Text Access

Tools